Engineering tumor stromal mechanics for improved T cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering tumor stromal mechanics for improved T cell therapy

Published:2022-04 Issue:4 Volume:1866 Page:130095
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Ying Linxuan,Yazdani Mahsa,Koya Richard,Zhao Ruogang

Funder

National Institutes of Health

National Heart Lung and Blood Institute

American Lung Association

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference45 articles.

1. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1;Robbins;J. Clin. Oncol.,2011

2. Genetic engineering of T cells for immunotherapy;Ellis;Nat. Rev. Genet.,2021

3. Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy;Jiang;Cancer Immunol. Immunother.,2017

4. Antifibrotic therapy disrupts stromal barriers and modulates the immune landscape in pancreatic ductal adenocarcinoma;Elahi-Gedwillo;Cancer Res.,2019

5. Collagen reorganization at the tumor-stromal interface facilitates local invasion;Provenzano;BMC Med.,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers;International Journal of Molecular Sciences;2024-06-15

2. Challenges and innovations in CAR-T cell therapy: a comprehensive analysis;Frontiers in Oncology;2024-06-11

3. A review of the REDOX properties of MoS2: From wastewater treatment to tumor therapy;Science China Materials;2024-01-23

4. The function of chitosan/agarose biopolymer on Fe ₂ O ₃ nanoparticles and evaluation of their effects on MCF ‐7 breast cancer cell line and expression of BCL2 and BAX genes;Biotechnology Progress;2022-11

5. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy;Frontiers in Immunology;2022-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3